Vigilance reporting is the ongoing regulatory obligation for medical device manufacturers, authorized representatives, and importers to notify competent authorities about serious incidents, deaths, or health-related events linked to a marketed device. It operates within post-market surveillance and generates field safety notices, periodic summary reports, adverse trend analyses, and risk management records that regulators may inspect during audits or compliance reviews.
Vigilance reporting content appears in adverse event narratives, field safety notices, periodic summary reports, and correspondence with competent regulatory authorities. Translators working on these submissions must preserve report categories, event dates, severity terms, and anonymized patient details so that the translated text meets the destination regulator’s format and reporting expectations.
A frequent error is translating “vigilance” as if it meant passive monitoring or surveillance, which weakens the sense of a mandatory reporting duty. Underplaying that duty in a field safety notice or adverse event report can make a required submission read like an optional update, or lead to inconsistent severity classification across languages.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →